176 related articles for article (PubMed ID: 37497407)
1. CAVIN2/SDPR Functioned as a Tumor Suppressor in Lung Adenocarcinoma from Systematic Analysis of Caveolae-Related Genes and Experimental Validation.
Zhu K; Wang B; Li Y; Yu Y; Chen Z; Yue H; Meng Q; Tian D; Liu X; Shen W; Tian Y
J Cancer; 2023; 14(11):2001-2014. PubMed ID: 37497407
[No Abstract] [Full Text] [Related]
2. Integrated Bioinformatic Analysis of the Expression and Prognosis of Caveolae-Related Genes in Human Breast Cancer.
Tian Y; Liu X; Hu J; Zhang H; Wang B; Li Y; Fu L; Su R; Yu Y
Front Oncol; 2021; 11():703501. PubMed ID: 34513683
[TBL] [Abstract][Full Text] [Related]
3. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
4. Similar regulatory mechanisms of caveolins and cavins by myocardin family coactivators in arterial and bladder smooth muscle.
Zhu B; Rippe C; Thi Hien T; Zeng J; Albinsson S; Stenkula KG; Uvelius B; Swärd K
PLoS One; 2017; 12(5):e0176759. PubMed ID: 28542204
[TBL] [Abstract][Full Text] [Related]
5. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma.
Pan M; Huang P; Li L; Lei P; Fang L; Zhao L; Li Y; Huang S; Luo W
J Thorac Dis; 2023 Apr; 15(4):1872-1891. PubMed ID: 37197486
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer.
Luo X; Peng S; Ding S; Zeng Q; Wang R; Ma Y; Chen S; Wang Y; Wang W
Cancer Cell Int; 2021 Jan; 21(1):49. PubMed ID: 33435990
[TBL] [Abstract][Full Text] [Related]
9. UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.
Cen X; Chen Q; Wang B; Xu H; Wang X; Ling Y; Zhang X; Qin D
Cell Commun Signal; 2022 Nov; 20(1):191. PubMed ID: 36443833
[TBL] [Abstract][Full Text] [Related]
10. Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.
Chen R; Wang Z; Lu T; Liu Y; Ji Y; Yu Y; Tou F; Guo S
Thorac Cancer; 2023 Apr; 14(10):893-912. PubMed ID: 36825773
[TBL] [Abstract][Full Text] [Related]
11. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
13. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma.
Jiang W; Wei Q; Xie H; Wu D; He H; Lv X
Anal Cell Pathol (Amst); 2023; 2023():4522045. PubMed ID: 37416927
[TBL] [Abstract][Full Text] [Related]
14. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer.
Wang J; Yang Q; Tang M; Liu W
Front Oncol; 2022; 12():911316. PubMed ID: 35957916
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
Hansson B; Rippe C; Kotowska D; Wasserstrom S; Säll J; Göransson O; Swärd K; Stenkula KG
PLoS One; 2017; 12(3):e0173412. PubMed ID: 28278164
[TBL] [Abstract][Full Text] [Related]
16. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
Yang X; Wang G; Gu R; Xu X; Zhu G
PeerJ; 2020; 8():e10418. PubMed ID: 33304656
[TBL] [Abstract][Full Text] [Related]
17. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
18. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
Hou G; Lu Z; Bi Y; Deng J; Yang X
Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma.
Ma X; Yang S; Jiang H; Wang Y; Xiang Z
J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056
[TBL] [Abstract][Full Text] [Related]
20. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
